SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lupin’s arm incorporates wholly owned subsidiary in New Zealand

08 Aug 2024 Evaluate

Lupin’s wholly owned subsidiary -- Generic Health, Australia has incorporated wholly owned subsidiary namely Lupin NZ, New Zealand. Lupin NZ will be engaged in the business of pharmaceuticals and pharmaceutical devices in New Zealand. Lupin NZ was incorporated under Certificate of Incorporation dated August 8, 2024, issued by the Registrar of Companies New Zealand under the Companies Act 1993. 

Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.


Lupin Share Price

2259.95 14.30 (0.64%)
12-May-2026 09:09 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1877.85
Dr. Reddys Lab 1281.85
Cipla 1308.55
Zydus Lifesciences 998.65
Lupin 2259.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×